$FCX, $LH, $MELI, $MYGN
Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:
Freeport-McMoran Inc. (NYSE:FCX) analysts reiterated with an Outperform rating at Cowen. The analysts feel the company is making positive progress in Indonesia, with the biggest incremental development being that company management is comfortable that a reasonable fair market price will be paid for any divestment of Grasberg. The 52-wk trading range for the company is 11.05 – 20.25. The consensus price target is 19.16. .
Laboratory Corp. Inc. (NYSE:LH) had coverage resumed at Goldman Sachs as the stock was returned to the firm’s Conviction Buy list. The 52-wk trading range is 128 – 177.80. The consensus price objective is 181.69.
Mercadolibre Inc. (NASDAQ:MELI) saw its price target raised to 415 from 350 at Stifel. The analysts believe strong sales momentum continued through the Holiday season particularly in Brazil and Mexico on the back of investments in free shipping, customer loyalty and marketing. The 52-wk trading range for the shares is 180.22 – 383.69. The consensus price objective is posted at 305.64.
Myriad Genetics Inc. (NASDAQ:MYGN) was started with a Sell rating at Goldman Sachs. The 52-wk trading range is 15.15 – 41.57. The consensus price target is 31.22.
Latest posts by Paul Ebeling (see all)
- Michael Selsman’s New Judy Garland Book Promises the ‘Real’ Story of Judy’s Life. - January 23, 2019
- The Street’s Key Stock Analysts Research Reports - January 23, 2019
- Asia: Gold, USD, Crude Oil, Stocks & Commodities - January 23, 2019